- Home
- VCIG vs ASBP Comparison
VCIG vs ASBP Comparison
Compare VCIG & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCIG
- ASBP
- Stock Information
- Founded
- VCIG 2013
- ASBP 2021
- Country
- VCIG Malaysia
- ASBP United States
- Employees
- VCIG N/A
- ASBP N/A
- Industry
- VCIG Diversified Commercial Services
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- VCIG Consumer Discretionary
- ASBP Health Care
- Exchange
- VCIG Nasdaq
- ASBP Nasdaq
- Market Cap
- VCIG 22.5M
- ASBP 26.6M
- IPO Year
- VCIG 2023
- ASBP N/A
- Fundamental
- Price
- VCIG $10.00
- ASBP $0.44
- Analyst Decision
- VCIG
- ASBP
- Analyst Count
- VCIG 0
- ASBP 0
- Target Price
- VCIG N/A
- ASBP N/A
- AVG Volume (30 Days)
- VCIG 186.6K
- ASBP 4.3M
- Earning Date
- VCIG 11-19-2025
- ASBP 08-13-2025
- Dividend Yield
- VCIG N/A
- ASBP N/A
- EPS Growth
- VCIG N/A
- ASBP N/A
- EPS
- VCIG N/A
- ASBP N/A
- Revenue
- VCIG $27,819,290.00
- ASBP N/A
- Revenue This Year
- VCIG N/A
- ASBP N/A
- Revenue Next Year
- VCIG N/A
- ASBP N/A
- P/E Ratio
- VCIG $1.79
- ASBP N/A
- Revenue Growth
- VCIG 36.99
- ASBP N/A
- 52 Week Low
- VCIG $9.50
- ASBP $0.22
- 52 Week High
- VCIG $5,292.00
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- VCIG 28.32
- ASBP 46.22
- Support Level
- VCIG $9.50
- ASBP $0.41
- Resistance Level
- VCIG $15.45
- ASBP $0.47
- Average True Range (ATR)
- VCIG 2.64
- ASBP 0.05
- MACD
- VCIG -0.83
- ASBP -0.01
- Stochastic Oscillator
- VCIG 3.14
- ASBP 31.24
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.